YOLFTbeta
Talphera Inc.

Talphera Inc.

TLPH · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic

0.906USD-0.13 (-12.46%)

Price History

Full chart

Market Stats

Previous Close1.04
Open0.9898
Day Range0.77 – 1.01
52-Week Range0.6866 – 1.57
Volume1.22M
Market Cap61.77M
P/E (TTM)0.00
Forward P/E1.02
EPS-0.23
Dividend Yield0.00%
Beta0.69
50-Day Avg1.25
200-Day Avg1.02

About

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Vincent J. Angotti
  • Employees12
  • Headquarters1850 Gateway Drive, San Mateo, CA, United States, 94404, USA
  • Websitehttps://talphera.com

Leadership

  • Mr. Vincent J. AngottiCEO & Director · b. 1968
  • Mr. Raffi Mark AsadorianChief Financial Officer · b. 1969
  • Dr. Shakil Aslam M.D.Chief Medical Officer · b. 1965
  • Mr. Anil N. DasuChief Engineering Officer · b. 1963

Financials

Income Statement

Currency: USD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue----1.07M2.39M29.50M5.22M19.26M17.36M8.00M2.15M2.29M5.42M378.00K1.77M651.00K028.00K
Growth (%)-----+123.32%+1132.33%-82.32%+269.24%-9.89%-53.94%-73.10%+6.42%+136.61%-93.02%+368.52%-63.24%-100.00%-
Cost of Revenue216.00K383.00K481.00K479.00K-605.00K26.29M24.52M24.26M12.31M10.66M3.98M6.81M6.03M3.01M1.65M5.55M6.72M-
Gross Profit-216.00K-383.00K-481.00K-479.00K1.07M1.79M3.21M-19.30M-5.00M5.04M-2.66M-1.82M-4.52M-616.00K-2.63M-1.65M-4.89M-6.72M28.00K
Gross Margin----100.00%74.73%10.88%-370.00%-25.93%29.05%-33.32%-84.84%-197.34%-11.37%-695.24%-93.00%-751.92%-100.00%
Operating Expense10.07M20.31M18.55M11.71M20.42M31.50M9.88M18.35M14.20M37.00M36.02M33.90M49.69M40.35M15.49M18.70M11.99M8.53M13.51M
Operating Income-10.29M-20.69M-19.03M-12.19M-19.35M-29.71M-6.67M-37.65M-19.20M-31.96M-38.68M-35.73M-54.20M-40.96M-18.12M-20.35M-16.89M-15.25M-13.48M
Operating Margin-----1805.22%-1241.14%-22.60%-721.66%-99.66%-184.12%-483.83%-1660.95%-2368.06%-756.33%-4792.59%-1149.18%-2594.32%--48157.14%
EBITDA-9.39M-19.88M-18.40M-12.47M-17.28M-29.11M-6.07M-29.85M-16.25M-28.99M-36.43M-34.01M-49.03M-35.22M-12.88M61.90M-10.06M-12.51M-14.36M
EBITDA Margin-----1611.85%-1215.87%-20.59%-572.13%-84.36%-167.00%-455.63%-1581.31%-2142.16%-650.24%-3408.20%3495.26%-1544.85%--51296.43%
Net Income-9.63M-20.66M-20.12M-14.34M-20.10M-33.36M-23.43M-33.35M-24.40M-43.16M-51.51M-47.15M-53.24M-40.38M-35.10M42.52M-18.40M-13.00M-14.29M
Net Income Margin-----1875.09%-1393.61%-79.40%-639.31%-126.66%-248.64%-644.25%-2191.96%-2325.91%-745.55%-9285.45%2400.62%-2825.96%--51035.71%
R&D8.21M18.32M15.50M8.19M13.62M24.91M26.29M24.52M22.49M21.40M19.41M13.14M4.66M4.02M2.44M1.69M5.55M6.72M6.03M
R&D as % of Total Revenue----1270.90%1040.43%89.12%470.00%116.74%123.30%242.76%610.74%203.63%74.17%644.18%95.65%851.92%-21546.43%
Interest Expense25.00K404.00K1.24M1.40M2.31M3.65M16.76M2.64M5.41M12.15M14.04M12.56M2.54M3.31M2.29M1.12M134.00K394.00K0
Interest Expense % of Total Revenue----215.39%152.46%56.81%50.58%28.06%70.01%175.57%583.82%110.75%61.02%606.08%63.02%20.58%-0.00%

Balance Sheet

Currency: USD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-22.68M14.49M6.83M40.84M64.52M110.03M86.42M127.78M99.99M75.55M120.53M91.36M66.30M77.89M47.49M20.39M18.24M29.72M
Total Liabilities-56.01M67.48M72.72M23.37M30.67M36.87M39.76M94.67M105.33M112.06M116.28M132.77M122.05M113.79M25.67M6.29M10.24M12.68M
Total Equity--33.34M-52.99M-65.89M17.47M33.85M73.16M46.66M33.11M-5.34M-36.51M4.25M-41.42M-55.75M-35.89M21.81M14.11M8.00M17.04M
Cash-6.07M7.15M3.06M7.79M47.93M88.40M60.04M107.92M80.31M52.90M87.97M14.68M27.27M7.66M15.28M5.72M8.86M5.89M
Total Debt-12.33M9.73M12.01M19.08M15.97M14.36M24.87M84.53M94.54M102.68M105.67M121.79M25.60M18.62M10.02M-6.53M6.50M
Net Debt-6.26M2.58M8.95M11.29M-31.96M-74.04M-35.16M-23.39M14.23M49.78M17.70M107.11M-1.68M10.96M-5.25M-5.72M-2.34M605.00K

Cash Flow

Currency: USD2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.86M-18.90M-19.42M-12.22M-15.29M-24.58M-487.00K-34.46M-19.95M-29.39M-29.77M-29.07M-51.18M-38.51M-30.00M-28.33M-17.49M-12.68M-11.36M
Investing Cash Flow-2.22M-9.94M8.62M4.76M-29.58M14.96M-6.92M-5.78M8.20M1.81M-9.97M-10.88M-36.56M34.14M-26.12M36.45M-528.00K3.78M-14.35M
Financing Cash Flow525.00K31.90M11.88M3.37M49.60M49.77M47.88M11.87M59.63M-26.00K12.33M75.03M14.45M16.96M41.51M-507.00K3.47M12.04M22.74M
Capital Expenditure1.56M547.00K111.00K4.00K2.02M826.00K3.29M5.50M1.46M3.72M2.40M819.00K3.47M1.85M1.83M364.00K100.00K00
Free Cash Flow-10.42M-19.45M-19.53M-12.23M-17.31M-25.41M-3.77M-39.96M-21.41M-33.12M-32.17M-29.89M-54.65M-40.36M-31.83M-28.70M-17.59M-12.68M-11.36M
FCF to OCF117.58%102.89%100.57%100.03%113.21%103.36%774.95%115.98%107.30%112.66%108.08%102.82%106.78%104.82%106.09%101.28%100.57%100.00%100.00%

Earnings

Report DateMar 24, 2011May 12, 2011Aug 11, 2011Nov 8, 2011Mar 20, 2012May 8, 2012Aug 9, 2012Nov 6, 2012Mar 13, 2013May 8, 2013Aug 12, 2013Nov 5, 2013Mar 3, 2014May 8, 2014Aug 11, 2014Nov 10, 2014Mar 9, 2015May 4, 2015Aug 3, 2015Oct 29, 2015Mar 7, 2016May 2, 2016Jul 28, 2016Nov 1, 2016Mar 2, 2017May 8, 2017Aug 1, 2017Nov 9, 2017Mar 8, 2018May 9, 2018Aug 2, 2018Nov 2, 2018Mar 7, 2019May 8, 2019Aug 5, 2019Nov 7, 2019Mar 16, 2020May 11, 2020Aug 10, 2020Nov 5, 2020Mar 15, 2021May 17, 2021Aug 16, 2021Nov 15, 2021Mar 10, 2022May 16, 2022Aug 11, 2022Nov 14, 2022Mar 30, 2023May 10, 2023Aug 10, 2023Nov 8, 2023Mar 6, 2024May 14, 2024Aug 14, 2024Nov 13, 2024Mar 4, 2025May 14, 2025Aug 14, 2025Nov 12, 2025Mar 23, 2026May 13, 2026Aug 12, 2026Nov 11, 2026
EPS Estimate--4.47-7.20-6.50--7.00-7.85-7.52--5.40-5.06-3.90-0.17-4.80-5.20-4.40-0.30-4.76-4.87-5.00-0.10-3.85-4.16-4.60-0.24-5.44-5.64-5.37-0.20-5.00-3.80-4.06-0.20-4.36-4.52-4.20-3.67-0.17-2.40-1.80-0.10-1.70-1.60-1.40-0.07-1.20-1.20-1.20-0.10-0.51-0.53-0.26-0.20-0.21-0.20-0.20-0.16-0.14-0.11-0.11-0.07-0.08-0.07-0.06
EPS Actual-3.64-6.00-5.00-6.00-7.35-7.20-7.00-7.60-8.20-6.80-4.40-4.20-0.22-4.40-4.800.40-0.23-4.23-4.022.20-0.25-4.80-4.80-5.00-0.21-6.80-5.80-5.60-0.20-4.60-4.00-4.20-0.18-3.40-3.20-3.20-3.60-0.20-1.60-2.00-0.10-1.60-1.60-1.40-0.06-1.20-1.15-0.94-1.00-0.75-0.41-0.08-0.25-0.17-0.15-0.13-0.07-0.11-0.10-0.11-0.06-0.05-0.06-
Surprise--34.23%30.56%7.69%--2.86%10.83%-1.06%--25.93%13.04%-7.69%-29.41%8.33%7.69%109.09%23.33%11.13%17.45%144.00%-150.00%-24.68%-15.38%-8.70%12.50%-25.00%-2.84%-4.28%0.00%8.00%-5.26%-3.45%10.00%22.02%29.20%23.81%1.91%-17.65%33.33%-11.11%3.19%5.88%0.00%0.00%7.69%0.00%4.17%21.67%-900.00%-47.06%22.64%69.23%-25.00%19.05%25.00%35.00%56.25%21.43%9.09%0.00%20.00%37.50%14.29%-
Timing-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketPre-market-After-hoursAfter-hours-After-hoursAfter-hoursPre-market-Pre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap61.77M
Enterprise Value43.39M
Trailing P/E0.00
Forward P/E1.02
Price / Sales61767.90
Price / Book4.20
EPS-0.23
Book Value0.369
Revenue (TTM)1.00K
Gross Profit (TTM)-6.70M
EBITDA-15.16M
Profit Margin0.00%
Operating Margin-1474700.00%
Return on Equity-143.36%
Return on Assets-42.55%
Shares Outstanding51.91M
Shares Float25.23M
Beta0.69
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 3.13
  • Strong Buy
    1
  • Buy
    1

Ownership Breakdown

Institutions
46.03%
Insiders
21.41%
Retail / Other
32.56%

Top Institutional Holders

  • AIGH Capital Management, LLC
    4.60M8.87%
  • Rock Springs Capital Management LP
    3.59M6.91%
  • Nantahala Capital Management, LLC
    3.49M6.73%
  • Rosalind Advisors, Inc.
    3.35M6.46%
  • Bleichroeder LP
    1.31M2.52%
  • CANTOR FITZGERALD, L. P.
    887.48K1.71%
  • Caption Management, LLC
    561.82K1.08%
  • Almitas Capital LLC
    467.15K0.90%
  • Vanguard Capital Management, LLC
    441.61K0.85%
  • Dauntless Investment Group, LLC
    435.23K0.84%
  • Geode Capital Management, LLC
    419.98K0.81%
  • Shay Capital LLC
    250.08K0.48%
  • Renaissance Technologies Corp
    237.75K0.46%
  • GSA Capital Partners LLP
    209.35K0.40%
  • Vanguard Fiduciary Trust Co
    192.41K0.37%
  • Diadema Partners LP
    153.56K0.30%
  • Mariner Wealth Advisors LLC
    100.00K0.19%
  • BlackRock Inc
    91.55K0.18%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    269.47K0.52%
  • Fidelity Extended Market Index
    214.96K0.41%

Stock Splits

  • Oct 26, 20221:20